Drug Profile
Research programme: antioxidants - Antipodean Pharmaceuticals
Alternative Names: MitoE; MitoPBN; Phenylbutylnitrone - Antipodean PharmaceuticalsLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Antipodean Pharmaceuticals
- Class
- Mechanism of Action Antioxidants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Unspecified
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Undefined in New Zealand
- 07 Jun 2006 Preclinical trials in Undefined in New Zealand (unspecified route)